Related Experiment Video
Updated: Aug 1, 2026

Intracranial Injection of Adeno-associated Viral Vectors
Published on: November 17, 2010
Case report on meningoenceplapathy in an Indian patient post CoViD vaccination
Raj Kamal Choudhry1, Amrendra Kumar Singh1, Kumar Sourav1
1Jawaharlal Nehru Medical College and Hospital, Bhagalpur, Bihar, India.
Abstract:
The SARS-COV-2 infection-related severe illness is prevented by vaccinations. Therefore, it is relevant to report a case of post vaccine meningoencephalitis in a 30 year old male Indian patient, who presented with weakness in all the extremities, episodes of loose stool, fever, vomiting, tachypnea and loss of consciousness immediately following the 2nd dose of the COVID vaccination (COVAXIN).
Insights
COVID-19 vaccination (COVAXIN) prevents severe illness. This report details a rare case of meningoencephalitis in a 30-year-old Indian male following his second vaccine dose.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Vaccination is crucial for preventing severe COVID-19.
- Adverse events following immunization require thorough investigation.
Purpose of the Study:
- To report a case of meningoencephalitis after COVID-19 vaccination.
Main Methods:
- Case report of a 30-year-old Indian male.
Main Results:
- The patient developed meningoencephalitis immediately after the second dose of COVAXIN.
- Symptoms included limb weakness, diarrhea, fever, vomiting, rapid breathing, and loss of consciousness.
Conclusions:
- This case highlights a potential neurological adverse event post-COVID-19 vaccination.
- Further research is needed to understand the mechanisms and incidence of such events.
Related Concept Videos
Vaccinations
Viral Meningitis
Poliomyelitis
Arboviral Encephalitis
Cryptococcal Meningitis
Encephalitis l: Introduction

